av/aeon-biopharma--big.svg

AMEX:AEON

AEON Biopharma, Inc.

  • Stock

USD

Last Close

0.80

08/11 21:00

Market Cap

29.64M

Beta: -

Volume Today

246.50K

Avg: -

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.